Home > Clinical Trials
Check All Search

Saved trials

COMPLETED
NCT05320627
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
150 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Non-Valvular Atrial Fibrillation
ACTIVE_NOT_RECRUITING
NCT04639219
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
102 Enrollment(s)
30 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
COMPLETED
NCT04539938
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
70 Enrollment(s)
140 Study location(s)
INTERVENTIONAL (PHASE2)
HER2 Positive Breast Cancer
RECRUITING
NCT07307170
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
750 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Herpes Zoster


Mirogabalin


Pain
RECRUITING
NCT05735184
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
420 Enrollment(s)
44 Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia


Mixed Lineage Leukemia Gene Mutation


Refractory AML


AML With Mutated NPM1


Acute Myeloid Leukemia Recurrent


Acute Myeloid Leukemia, in Relapse


NPM1 Mutation


KMT2Ar


Myeloid Sarcoma


Nucleophosmin 1-mutated Acute Myeloid Leukemia
RECRUITING
NCT07451431
Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
78 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Diabetic Peripheral Neuropathic Pain (DPNP)
NOT_YET_RECRUITING
NCT07454668
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
20 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer


HER2-positive Breast Cancer


Brain Metastases


Cancer


Cancer Metastatic
RECRUITING
NCT06916520
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
300 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)


Percutaneous Coronary Intervention (PCI)